Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alpha-Bisabolol Gel With Antihistamine Action
NCT05022108Phase 1Completed
- Sponsor
- Universidade do Vale do Sapucaí
- Start
- Apr 2020
- Primary completion
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of alpha-bisabolol in allergic reaction, sponsored by Universidade do Vale do Sapucaí. Primary endpoint: Measure of the area sensitized with histamine at 15 minutes. Started Apr 2020; status: completed.
02
Drugs
alpha-bisabolol
03
Conditions
allergic reaction
Beyond the preview
Go deeper on NCT05022108.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05022108.